Vascular Endothelial Growth Factor Inhibitor [EPC] - N0000193543

  1. Home
  2. Pharmacologic Class Index
  3. Vascular Endothelial Growth Factor Inhibitor [EPC] - N0000193543

Pharmacologic Class Information

Pharmacologic Code N0000193543
Pharmacologic Name Vascular Endothelial Growth Factor Inhibitor
Pharmacologic Uses
  • vascular endothelial growth factor (VEGF) inhibitor
  • vascular endothelial growth factor-specific angiogenesis inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Vascular Endothelial Growth Factor Inhibitor

The table contains 21 products whose active ingredient are classified under the same pharmacologic class Vascular Endothelial Growth Factor Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0024-5840Zaltrap Non-Proprietary Name: Ziv-afliberceptSolution, ConcentrateIntravenousSanofi-aventis U.s. LlcACTIVE
0024-5841Zaltrap Non-Proprietary Name: Ziv-afliberceptSolution, ConcentrateIntravenousSanofi-aventis U.s. LlcACTIVE
0069-0315Zirabev Non-Proprietary Name: Bevacizumab-bvzrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
0069-0342Zirabev Non-Proprietary Name: Bevacizumab-bvzrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
50242-060Avastin Non-Proprietary Name: BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-061Avastin Non-Proprietary Name: BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-078Susvimo Non-Proprietary Name: RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
50242-080Lucentis Non-Proprietary Name: RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
50242-082Lucentis Non-Proprietary Name: RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
55513-206Mvasi Non-Proprietary Name: Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
55513-207Mvasi Non-Proprietary Name: Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
61755-005Eylea Non-Proprietary Name: AfliberceptInjection, SolutionIntravitrealRegeneron Pharmaceuticals, Inc.ACTIVE
61755-050Eylea Hd Non-Proprietary Name: AfliberceptInjection, SolutionIntravitrealRegeneron Pharmaceuticals, IncACTIVE
61755-051Eylea Hd Non-Proprietary Name: AfliberceptInjection, SolutionIntravitrealRegeneron Pharmaceuticals, IncACTIVE
64406-019Byooviz Non-Proprietary Name: Ranibizumab-nunaInjection, SolutionIntravitrealBiogen Inc.ACTIVE
70114-440Cimerli Non-Proprietary Name: Ranibizumab-eqrnInjection, SolutionIntravitrealCoherus Biosciences IncACTIVE
70114-441Cimerli Non-Proprietary Name: Ranibizumab-eqrnInjection, SolutionIntravitrealCoherus Biosciences IncACTIVE
70121-1754Alymsys Non-Proprietary Name: Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
70121-1755Alymsys Non-Proprietary Name: Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
72606-011Vegzelma Non-Proprietary Name: Bevacizumab-adcdInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
72606-012Vegzelma Non-Proprietary Name: Bevacizumab-adcdInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE